, Political Economy of HIV/AIDS in Developing Countries, pp.130-149
Eloge de la copie : le reverse-engineering des antirétroviraux contre le VIH/ sida dans les laboratoires pharmaceutiques brésiliens, Sciences Sociales et Santé, n°, vol.3, pp.77-103, 2009. ,
Public Choices in the Pharmaceutical Sector : a Case Study of Brazil, Human development Department, vol.54, 2000. ,
, Integrating Property Rights and Development Policy, COMMISSION ON INTELLECTUAL PROPERTY RIGHTS, 2002.
Guidelines for the examination of pharmaceutical patents: developing a public health perspective. ICTSD, WHO, UNCTAD, 2007. ,
« Global Pharmaceutical markets and corporate citizenship : the Case of Novartis' anti-cancer drug Glivec, Biosocieties, vol.3, pp.165-181, 2008. ,
Access to antiretroviral drugs in Brazil, The Lancet, vol.360, pp.1862-1865, 2002. ,
The introduction of pharmaceutical products patents in India : heartless exploitation of the poor and suffering ?, vol.54, 1997. ,
, Sida, santé publique et politique du médicament au Brésil : autonomie ou dépendance, vol.3, pp.47-75, 2009.
,
, ANRS Collection Sciences sociales et sida NATIONAL ACADEMY OF SCIENCE, 1997, « America's vital interest in global Health : protecting our people, Enhancing our economy and advancing our international interest, Issues and challenge
Etat et l'invention : histoire des brevets, 1986. ,
, Technology transfer, dependence, and self-reliant development in the third world, vol.250, 1998.
« Post Trips Options for Access To Patented Medicines in Developing Countries, Commission on Macroeconomics and Health, WHO, vol.77, 2001. ,
The Brazilian experience in providing universal access to antiretroviral therapy, ANRS Collection Sciences sociales et sida, p.69, 2003. ,
Le droit à la santé et aux médicaments. Le cas de la récente négociation sur la stratégie mondiale sur la santé publique, l'innovation et la propriété intellectuelle, OMS, pp.1-13, 2009. ,